Madhav J. Jamdar
5 IP cases indexed. Covers patent, trademark matters.
Cases Presided Over
5 cases indexed | Page 1 of 1
Safex Chemical India Ltd. v.The Controller of Patents & Designs
Safex Chemical India Ltd. challenged the Controller's decision to grant a patent for a 'Novel Agricultural Composition,' arguing that the Petitioner was denied natural justice because they were not informed about the allowance of Respondent No. 2's amendments before the pre-grant opposition hearing. The petitioner contended this procedural lapse rendered the granted patent invalid. However, the Bombay High Court ultimately disposed of the Writ Petition, noting that the petitioner had already availed and was actively pursuing the alternate remedy under Section 25(2) of the Patents Act.
Xotik Frujus Pvt. Ltd. v.Visat Beverages (Od)
The plaintiff, Xotik Frujus Pvt. Ltd., filed an interim application alleging that the defendant, Visat Beverages (Od), was infringing its registered trademarks and copyright related to its popular fruit drink 'JEERU'. The plaintiff argued that the defendant's product bore a slavish imitation of the plaintiff's mark and label. The court granted temporary relief in the form of an injunction and appointed a Court Receiver.
Chutraram Nemaram Gehlot v.Rajaram Magharam Tak
The Plaintiff filed an interim application seeking ad-interim relief against the Defendant for infringement of registered Trade Marks ('Prem Dulhan') and copyrighted artistic work ('PREM DULHAN GREEN LABEL'). The court found prima facie evidence establishing that the Defendant's use of 'DABANG DULHAN' is deceptively similar to the Plaintiff's established marks. Consequently, the court granted an ad-interim injunction.
Dexpo Intelectual Properties Services Ltd. v.Nilesh Patel
The dispute between Dexpo Intelectual Properties Services Ltd. and Nilesh Patel was amicably settled through Consent Terms dated 26th November, 2020. Both parties agreed to the terms, leading the court to allow the Leave Petition (L) No.9822 of 2020.
Ajanta Pharma Limited v.Saphnix Life Science
Ajanta Pharma Limited filed an interim application seeking relief against Saphnix Life Science for alleged infringement of its registered trade mark, ARTEFAN. The court examined the evidence showing that the defendant was using an identical trade mark on similar pharmaceutical preparations. Based on the prima facie case established by the plaintiff, the ad-interim injunction was granted.
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.